Valoración del tratamiento anticoagulante en pacientes diagnosticados de fibrilación auricular no valvular en una zona básica de salud / Assessment of anticoagulation treatments in non-valvular atrial fibrillation patients diagnosed in a basic health area

Introducción: La fibrilación auricular (FA) es la arritmia cardiaca más frecuente. En su manejo, es clave valorar la necesidad de anticoagulación. Nuestro objetivo fue valorar en pacientes diagnosticados de FA no valvular si la indicación de anticoagulación es adecuada en función de la escala CHA2DS2-VASc y la adecuación del rango del International Normalizad Ratio (INR) en los pacientes en tratamiento con antivitamina K. Métodos: Estudio observacional, analítico transversal. Se seleccionaron 232 pacientes con diagnóstico de FA no valvular. Se han analizado variables demográficas, variables de la escala CHA2DS2-VASc, tratamiento prescrito y valores de INR durante 6 meses consecutivos. La comparación de variables se realizó con ji cuadrado y la tendencia lineal entre grupos por Mantel Haenzel, siendo calculadas las odds ratios. Resultados: La prevalencia total de FA no valvular en el área fue 1,05%. El 88,4% presentó un CHA2DS2-VASc ≥ 2. Un 71,1% de pacientes con fibrilación auricular estaban anticoagulados, de los que el 58,2% tomaban fármacos antivitamina K. El 46,7% de los pacientes en tratamiento con acenocumarol presentó un INR con un tiempo en rango terapéutico directo insuficiente. La prescripción de antivitamina K en los pacientes con FA permanente fue superior que en pacientes con FA paroxística (62,8 vs. 37,2%, p<0,001). El consumo de fármacos que aumentan el sangrado se asoció a un peor control de INR (tras ajuste por las principales variables de relevancia clínica (odds ratio 2,17 [1,02-4,59], p=0,043). Conclusiones: El control de la anticoagulación oral con antivitamina K fue subóptimo pese a la adecuada adherencia de los pacientes. Los pacientes con FA paroxística recibieron menos antivitamina-K que los de FA persistente/permanente (AU)

Introduction: Atrial fibrillation (AF) is the most common cardiac arrhythmia. To assess the need for anticoagulation is essential for its management. Our objective was to investigate whether the indication of anticoagulation was adequate in patients diagnosed with non-valvular AF, given the CHA2-DS2-VASc scale, measuring the International Normalizad Ratio range (INR) in patients treated with anti-vitamin K drugs. Methods: This is an observational and cross sectional study. 232 patients with atrial fibrillation were included. We analyzed demographic, the CHA2-DS2-VASc and HAS-BLED variables, the treatment and INR values for 6 consequentive months. The confrontation of variables was performed using chi-square and Mantel-Haenzel test. Results: The prevalence of AF was 1.05%. The 88.4% had CHA2-DS2-VASc ≥ 2. The 71.1% were taking anticoagulants, of which 58.2% were under antivitamin k. The 46.7% of patients taking antivitamin K, presented inadequate range of INR. There was a greater prescription of antivitamin k in patients with persistent or permanent AF compared to the paroxysmal form (62.8 vs. 37.2% p<.001). The use of drugs that increase bleeding was associated with a worse control of INR after adjustment for the main variables of clinical relevance (odds ratio 2.17 [1.02-4.59], p=.043). Conclusions: The level of anticoagulation with antivitamin K was inadequate in our sample, despite a proper follow up and adherence to treatment. Patients with paroxysmal AF received less antivitamin K than those with persistent/permanent AF (AU)

Assessment of anticoagulation treatments in non-valvular atrial fibrillation patients diagnosed in a basic health area. / Valoración del tratamiento anticoagulante en pacientes diagnosticados de fibrilación auricular no valvular en una zona básica de salud.

INTRODUCTION: Atrial fibrillation (AF) is the most common cardiac arrhythmia. To assess the need for anticoagulation is essential for its management. Our objective was to investigate whether the indication of anticoagulation was adequate in patients diagnosed with non-valvular AF, given the CHA2-DS2-VASc scale, measuring the International Normalizad Ratio range (INR) in patients treated with anti-vitamin K drugs. METHODS: This is an observational and cross sectional study. 232 patients with atrial fibrillation were included. We analyzed demographic, the CHA2-DS2-VASc and HAS-BLED variables, the treatment and INR values for 6 consequentive months. The confrontation of variables was performed using chi-square and Mantel-Haenzel test. RESULTS: The prevalence of AF was 1.05%. The 88.4% had CHA2-DS2-VASc ≥ 2. The 71.1% were taking anticoagulants, of which 58.2% were under antivitamin k. The 46.7% of patients taking antivitamin K, presented inadequate range of INR. There was a greater prescription of antivitamin k in patients with persistent or permanent AF compared to the paroxysmal form (62.8 vs. 37.2% p<.001). The use of drugs that increase bleeding was associated with a worse control of INR after adjustment for the main variables of clinical relevance (odds ratio 2.17 [1.02-4.59], p=.043). CONCLUSIONS: The level of anticoagulation with antivitamin K was inadequate in our sample, despite a proper follow up and adherence to treatment. Patients with paroxysmal AF received less antivitamin K than those with persistent/permanent AF.

Respuesta de los autores. Ejercicio y diabetes mellitus tipo 2 / Author's reply. Exercise and Type 2 Diabetes Mellitus

No disponible

Mejora en el control de los diabéticos tipo 2 tras una intervención conjunta: educación diabetológica y ejercicio físico / Improvement of control in subjects with type 2 diabetes after a joint intervention: diabetes education and physical activity

ObjetivoConocer la mejora del control (metabólico, factores de riesgo cardiovascular), adherencia, autocontrol, autocuidados y actitudes/motivaciones de los diabéticos tipo 2 (DM2) de una zona de salud, tras intervención comunitaria grupal: educación diabetológica (ED) y ejercicio físico (EF).DiseñoEnsayo clínico aleatorizado controlado, simple ciego. Intervención: Grupo 1: ED grupal, Grupo 2: ED grupal y ejercicio físico, Grupo 3: solo ejercicio y Grupo 4 “control”: atención individual en consulta.EmplazamientoZona salud urbana (centro de salud/pabellón deportivo).Participantes108 DM2, 40-70 años, hemoglobina glucosilada (HbA1c) ≤ 8,5%, tensión arterial (TA)<160/90 e índice de masa corporal (IMC)<45, excluyéndose aquellos con complicaciones crónicas y/o descompensación aguda.IntervencionesDurante 6 meses, se realizaron 8 talleres de educación grupal y ejercicio físico monitorizado de intensidad moderada, 3 horas/semana.Mediciones principalesPre y post-intervención variable principal: descenso de HbA1c; demás variables: datos exploratorios, analíticos, cumplimiento terapéutico, autocontrol, autocuidados, actitudes y motivaciones (encuesta DAS-3sp).ResultadosTras intervenciones, más diabéticos bajaban HbA1c con intervención plena “ED y EF”, RR: 1,93 (0,85-4,40), así como con ejercicio, RR: 1,56 (0,65-3,76). Con ED y EF simultáneo, más sujetos descendieron IMC, RR: 1,61 (0,85-3,03) y LDL-colesterol, RR: 1,82 (0,99-3,36), aumentando cumplimiento dietético, RR: 1,29 (0,32-5,22) y de ejercicio, RR: 1,93 (0,76-4,91), realizando más autocontroles/semana, RR: 3,86 (0,90-16,55) y mejorando motivaciones/actitudes en “valoración del control estricto”, RR: 1,48 (0,94-2,34). Con ejercicio aislado la TA sistólica y diastólica descendió en más pacientes, RR: 1,35 (0,72-2,52), 1,87 (0,72-4,84), mientras que con ED grupal solo la diastólica, RR: 1,80 (0,69-4,67)(AU)

ConclusionesLos pacientes mejoran más con la combinación de ED y EF, aunque los resultados no sean estadísticamente significativos, probablemente por insuficiente tamaño muestral(AU)

ObjectiveTo study the improvement of metabolic control and cardiovascular risk factors, adherence, self-monitoring, self-care, attitudes and motivation in subjects with Type 2 Diabetes (DM2) in a specific Health Care Area after group intervention through the community: diabetes education (DE) and physical exercise (PE).DesignA single blind, randomised controlled clinical trial. Intervention: group 1: DE; group 2: ED and PE; group 3: only PE, and “control” group-4: Individual consultations.LocationUrban health centre/municipal sports centre.Participants108 DM2, age: 40-70, glycated haemoglobin (HbA1c) ≤ 8.5%, blood pressure (BP)<160/90 and body mass index (BMI)<45, excluding those with chronic complications and/or acute decompensation.InterventionsDuring 6 months, 8 workshops were held for group education and monitored aerobic physical exercise of moderate intensity (3hours a week).Main measurementsPrimary variable pre- and post- intervention: reduction in HbA1c; other variables: examination and analytical data, therapeutic compliance, self-monitoring, self-care, attitudes and motivation (DAS-3SP survey).ResultsAfter intervention, more diabetics had a lower HbA1c following a full intervention: “DE” and “PE”, RR: 1.93 (0.85-4.40) and exercise, RR: 1.56 (0.65-3.76). With simultaneous DE and PE, the BMI, RR: 1.61 (0.85-3.03) and LDL cholesterol, RR: 1.82 (0.99-3.36), of many subjects decreased. Dietary compliance, RR: 1.29 (0.32-5.22) and exercise, RR: 1.93 (0.76-4.91) also increased, more patients performing their own checks, RR: 3.86 (0.90-16.55) and improving motivation/attitudes in “strict control management”, RR: 1.48 (0.94-2.34). With PE, systolic and diastolic BP decreased in more patients RR: 1.35 (0.72-2.52), 1.87 (0.72-4.84) while in the DE group only diastolic values decreased 1.80 (0.69-4.67)(AU)

ConclusionsPatient conditions improve more with the combination of DE and PE, though the results are not statistically significant, probably due to insufficient sample size(AU)

[Improvement of control in subjects with type 2 diabetes after a joint intervention: diabetes education and physical activity]. / Mejora en el control de los diabéticos tipo 2 tras una intervención conjunta: educación diabetológica y ejercicio físico.

OBJECTIVE: To study the improvement of metabolic control and cardiovascular risk factors, adherence, self-monitoring, self-care, attitudes and motivation in subjects with Type 2 Diabetes (DM2) in a specific Health Care Area after group intervention through the community: diabetes education (DE) and physical exercise (PE). DESIGN: A single blind, randomised controlled clinical trial. INTERVENTION: group 1: DE; group 2: ED and PE; group 3: only PE, and "control" group-4: Individual consultations. LOCATION: Urban health centre/municipal sports centre. PARTICIPANTS: 108 DM2, age: 40-70, glycated haemoglobin (HbA(1)c) ≤ 8.5%, blood pressure (BP)<160/90 and body mass index (BMI)<45, excluding those with chronic complications and/or acute decompensation. INTERVENTIONS: During 6 months, 8 workshops were held for group education and monitored aerobic physical exercise of moderate intensity (3 hours a week). MAIN MEASUREMENTS: Primary variable pre- and post- intervention: reduction in HbA(1)c; other variables: examination and analytical data, therapeutic compliance, self-monitoring, self-care, attitudes and motivation (DAS-3SP survey). RESULTS: After intervention, more diabetics had a lower HbA(1)c following a full intervention: "DE" and "PE", RR: 1.93 (0.85-4.40) and exercise, RR: 1.56 (0.65-3.76). With simultaneous DE and PE, the BMI, RR: 1.61 (0.85-3.03) and LDL cholesterol, RR: 1.82 (0.99-3.36), of many subjects decreased. Dietary compliance, RR: 1.29 (0.32-5.22) and exercise, RR: 1.93 (0.76-4.91) also increased, more patients performing their own checks, RR: 3.86 (0.90-16.55) and improving motivation/attitudes in "strict control management", RR: 1.48 (0.94-2.34). With PE, systolic and diastolic BP decreased in more patients RR: 1.35 (0.72-2.52), 1.87 (0.72-4.84) while in the DE group only diastolic values decreased 1.80 (0.69-4.67). CONCLUSIONS: Patient conditions improve more with the combination of DE and PE, though the results are not statistically significant, probably due to insufficient sample size.